These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19042967)

  • 1. History of the cholesterol controversy in Britain.
    Thompson GR
    QJM; 2009 Feb; 102(2):81-6. PubMed ID: 19042967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
    Pedersen TR; Kjekshus J; Berg K; Haghfelt T; Faergeman O; Faergeman G; Pyörälä K; Miettinen T; Wilhelmsen L; Olsson AG; Wedel H;
    Atheroscler Suppl; 2004 Oct; 5(3):81-7. PubMed ID: 15531279
    [No Abstract]   [Full Text] [Related]  

  • 3. Goals of statin therapy: three viewpoints. 2002.
    Thompson GR; Packard CJ; Stone NJ
    Atheroscler Suppl; 2004 Oct; 5(3):107-14. PubMed ID: 15531283
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.
    Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
    Atheroscler Suppl; 2004 Oct; 5(3):115-23. PubMed ID: 15531284
    [No Abstract]   [Full Text] [Related]  

  • 5. The statins in preventive cardiology.
    Steinberg D
    N Engl J Med; 2008 Oct; 359(14):1426-7. PubMed ID: 18832243
    [No Abstract]   [Full Text] [Related]  

  • 6. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy.
    Steinberg D
    J Lipid Res; 2006 Jul; 47(7):1339-51. PubMed ID: 16585781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brown and Goldstein: the cholesterol chronicles.
    Nair P
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14829-32. PubMed ID: 23980185
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol".
    Jukema JW; Simoons ML
    Acta Cardiol; 1999 Jun; 54(3):163-8. PubMed ID: 10478274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.
    Pedersen TR; Olsson AG; Faergeman O; Kjekshus J; Wedel H; Berg K; Wilhelmsen L; Haghfelt T; Thorgeirsson G; Pyörälä K; Miettinen T; Christophersen B; Tobert JA; Musliner TA; Cook TJ;
    Atheroscler Suppl; 2004 Oct; 5(3):99-106. PubMed ID: 15531282
    [No Abstract]   [Full Text] [Related]  

  • 12. Simvastatin: two decades in a circle.
    Kolovou GD; Katerina A; Ioannis V; Cokkinos DV
    Cardiovasc Ther; 2008; 26(2):166-78. PubMed ID: 18485137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in treatment of cholesterol abnormalities. The role of HMG-CoA reductase inhibitors.
    Rackley CE
    Postgrad Med; 1996 Nov; 100(5):61-5, 70-2. PubMed ID: 8917325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.
    Steinberg D; Gotto AM
    JAMA; 1999 Dec; 282(21):2043-50. PubMed ID: 10591387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK; White HD; Greaves SC
    N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expected versus observed survival in 3 large population studies with HMG-CoA reductase inhibitors.
    Naslafkih A; Sestier F
    J Insur Med; 2000; 32(3):155-62. PubMed ID: 15912915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the implications of over the counter statin sales.
    Nuttall M
    Nurs Times; 2004 May 25-31; 100(21):28-9. PubMed ID: 15192918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].
    Scheen AJ; Radermecker RP
    Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.